Diagnostic testing in the genetically complex age-related macular degeneration

Area of Science:

• Ophthalmology
• Genetics
• Public Health

Background:

• Age-related macular degeneration (AMD) is a primary cause of vision loss.
• Risk factors for AMD include genetic and environmental influences.
• Advancements in AMD treatments necessitate improved diagnostics and accessibility.

Purpose of the Study:

• To assess the feasibility of using polygenic risk scores (PRS) for evaluating genetic predisposition to AMD.
• To highlight the importance of genetic testing in the context of expanding AMD treatment options.
• To underscore the potential of early genetic confirmation for timely intervention and improved patient outcomes.

Main Methods:

• Utilized data from genome-wide association studies (GWAS).
• Generated polygenic risk scores (PRS) to quantify individual genetic risk for AMD.
• Analyzed the predictive accuracy of AMD-specific PRS.

Main Results:

• Polygenic risk scores (PRS) enable the assessment of genetic risk for AMD.
• The predictive accuracy of AMD-PRS is strongest in individuals with very high genetic risk.
• Genetic diagnostic testing for AMD is valuable given the disease's high prevalence.

Conclusions:

• Genetic testing, particularly PRS, can identify individuals at genetic risk for AMD.
• Early genetic confirmation of AMD pathology can lead to prompt treatment initiation.
• Timely intervention based on genetic insights may enhance patient outcomes in AMD management.